Events › B2B Event
B2B Event
The 15th Antibody Industrial Symposium (AIS2027) is a B2B trade show focused on antibody drug discovery, developability, immunotherapy, and bioprocessing, bringing together biotech professionals.
Exhibitor mix: Categorized by sponsorship level (Premium, Corporate, Bronze) and general exhibitors.
Filter this event to your ICP.
Dozens of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Organizer
LabEx MAbImprove and MabDesignNonprofit · Lyon, France · Founded 2014
French industrial association for the biotherapy sector, supporting the development of therapeutic antibodies and vaccines.
Why people attend
To find specialized biotech services, explore new bioprocessing technologies, and engage in B2B partnering for antibody drug development.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
Speakers
133 speakers at Antibody Industrial Symposium
Independent biotech Consultant · Lust for Life Science
"Mining Antibody Biology for Novel Functionalities and Therapeutic Antibody Development"
Also speaking at 14th Antibody Industrial Symposium
SVP Biology · EVOTEC
"Integrated Drug Discovery Continuum at Evotec"
Also speaking at 14th Antibody Industrial Symposium
Senior Research Scientist - In Vitro Biology · EVOTEC
"30 Years of Phage Display Supporting the Discovery of Meaningful Therapeutic Antibodies"
Also speaking at 14th Antibody Industrial Symposium
Research Scientist - Biophysics · EVOTEC
"Biophysical Interaction Mapping for Antibodies"
Also speaking at 14th Antibody Industrial Symposium
Group Leader - Bioservices and Welfare · EVOTEC
"De-Risking and Predicting the Behavior of Therapeutic Antibodies and Their Derivatives"
Also speaking at 14th Antibody Industrial Symposium
VP - Head of Molecular Architects · EVOTEC
"Antibody-Drug Conjugates (ADCs) Drug Discovery"
Also speaking at 14th Antibody Industrial Symposium
VP Immuno-Oncology - In Vitro Biology · EVOTEC
"Pharmacological Support for Antibody Discovery – Immune Synapse"
Also speaking at 14th Antibody Industrial Symposium
Senior Research Scientist - Immuno-Oncology In Vivo · EVOTEC
"Humanized Mouse Models Supporting Antibody Profiling"
Also speaking at 14th Antibody Industrial Symposium
Principal Scientist - Protein Sciences · EVOTEC
"Production, Early Developability Assessment and Affinity Maturation in Antibody Drug Discovery"
Also speaking at 14th Antibody Industrial Symposium
Associate VP - Business Development · JUST - EVOTEC BIOLOGICS
"Just’s Molecular Design and Manufacturing Platform"
Also speaking at 14th Antibody Industrial Symposium, Digital Construction Week
PU-PH - Head of the Clinical Hematology Department · Montpellier University Hospital
"How Antibody-Based Therapies Were Game Changers in the Treatment of Patients With Hematologic Cancers"
Also speaking at 14th Antibody Industrial Symposium
Head of the department of nuclear medicine · UZ Brussel, Vrije Universiteit Brussel
"Radiolabelled antibody fragments for use in treating cancer"
Also speaking at 14th Antibody Industrial Symposium
Professor · Vrije Universiteit Brussel
"Radiolabelled sdAb for radioligand therapy of cancer"
Also speaking at 14th Antibody Industrial Symposium
Group Leader · Institut de Recherche en Cancérologie Montpellier (IRCM)
"Antibody–radionuclide conjugates"
Also speaking at 14th Antibody Industrial Symposium
Field Application Scientist · Nuclera
"Cell-Free Triage of AI Antibodies Predicts CHO Kinetics"
Also speaking at 14th Antibody Industrial Symposium
Senior Director of Biologics Discovery Microfuildics Team · SANOFI
"Organoid cultures / tumoroids for Drug Screening"
After completing his Ph.D. studies in 2009 in microfluidic chip field, Guillaume Mottet continued as postdoctoral fellow at Institut Curie in the team of Jean Louis Viovy and developed thermoplastic chips for diagnostics. In 2013, he went on to apply droplet microfluidics for the study of molecular evolution in the lab of Andrew Griffiths at ESPCI, and in 2015 he joined the team of Pierre Bruhns at Institut Pasteur, where he implemented a single-cell droplet microfluidic platform for high throughput B cell analysis. Now at Sanofi, he is taking on a leading role in the microfluidics team with the goal to develop new technology for drug discovery.
Also speaking at 14th Antibody Industrial Symposium
+ 117 more speakers at this event.
More events in France
Frequently asked questions